Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
17 August, 2018 03:14 IST
Lupin gets USFDA nod for generic Tamiflu capsules
Source: IRIS | 10 Jan, 2018, 03.04PM
Comments  |  Post Comment

Pharma Major Lupin announced that it has received final approval for its Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) from the United States Food and Drug Administration (FDA) to market a generic version of Hoffman-La Roche, Inc.'s Tamiflu Capsules, 30 mg, 45 mg, and 75 mg.

Lupin's Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) are the AB rated generic equivalent of Hoffman-La Roche, Inc.'s Tamiflu Capsules, 30 mg, 45 mg, and 75 mg. Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) are indicated for the treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, and prophylaxis of influenza A and B in patients 1 year and older.

Oseltamivir Phosphate Capsules USP, 30 mg, 45 mg, and 75 mg had annual sales of approximately USD 467.8 million in the US. (IMS MAT October 2017).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
MCX inks MoU with Indian Bullion and Jewellers Association - 16-Aug-2018 15:31
Alfa Transformers bags order worth Rs 171.1 mn from Uttar Gujarat Vij Co - 16-Aug-2018 12:25
TVS Motor Co bets big on Philippines with new product launches - 16-Aug-2018 09:54
Sun Pharma gets USFDA approval for Cequa ophthalmic solution - 16-Aug-2018 09:33
TCS named leader in KYC-AML BPO services by Everest Group - 14-Aug-2018 12:04
MCX to commence trading in rubber futures on August 16 - 14-Aug-2018 11:53
Cadila Healthcare acquires 51% stake in Windlas Healthcare - 13-Aug-2018 15:52
RCom re-instates bank guarantees of Rs 7.74 bn with DOT - 13-Aug-2018 12:08
Larsen & Tubro wins construction order worth Rs 30.28 bn - 13-Aug-2018 11:51
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer